The sphingosine kinase activator K6PC-5 stimulates C2C12 myoblast differentiation

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 1, 2011, Pages 55-62

  Bernacchioni, C ^a   Cencetti, F ^a   Kwon, M J ^b   Gwak, H S ^b   Jeong, S K ^b   Bruni, P ^a   Donati, C ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b NeoPharm Co Ltd   (South Korea)

Author keywords

C2C12 myoblasts; K6PC 5; Myogenic differentiation; Sphingosine 1 phosphate; Sphingosine kinase

Indexed keywords

CERAMIDE; K6PC 5; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE KINASE 1; UNCLASSIFIED DRUG; AMIDE; N (1,3 DIHYDROXYISOPROPYL) 2 HEXYL 3 OXODECANAMIDE; N-(1,3-DIHYDROXYISOPROPYL)-2-HEXYL-3-OXODECANAMIDE; PHOSPHOTRANSFERASE; SPHINGOSINE KINASE; CERAMIDE DERIVATIVE; ENZYME ACTIVATOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; SPHINGOSINE KINASE ACTIVATOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; DRUG ACTIVITY; ENZYME ACTIVATION; MOUSE; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; PHYSIOLOGY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; IMMUNOFLUORESCENCE TEST; WESTERN BLOTTING;

AMIDES; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; ENZYME ACTIVATION; MICE; MUSCLE DEVELOPMENT; MYOBLASTS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECEPTORS, LYSOSPHINGOLIPID;

EID: 79957878587     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400107     Document Type: Article

References (22)

1. Fyrst H, Saba JD. An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat Chem Bio 2010; 6:489-97.
2. Pyne S, Pyne N. Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors. Pharmacol Ther 2000; 88:115-31. (Pubitemid 32057134)
3. Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003; 4:397-07.
4. Donati C, Meacci E, Nuti F, Becciolini L, Farnararo M, Bruni P. Sphingosine 1-phosphate regulates myogenic differentiation: a major role for S1P2 receptor. FASEB J 2005; 19:449-51. (Pubitemid 40316546)
5. Meacci E, Nuti F, Donati C, Cencetti F, Farnararo M, Bruni P. Sphingosine kinase activity is required for myogenic differentiation of C2C12 myoblasts. J Cell Physiol 2008; 214:210-20. (Pubitemid 350220075)
6. Donati C, Nincheri P, Cencetti F, Rapizzi E, Farnararo M, Bruni P. Tumor necrosis factor-alpha exerts pro-myogenic action in C2C12 myoblasts via sphingosine kinase/S1P2 signaling. FEBS Lett 2007; 581:4384-88. (Pubitemid 47368198)
7. Zanin M, Germinario E, Dalla LL, Sandona D, Sabbadini RA, Betto R, Danieli-Betto D. Trophic action of sphingosine 1-phosphate in denervated rat soleus muscle. Am J Physiol Cell Physiol 2008; 294:36-46.
8. Danieli-Betto D, Peron S, Germinario E, Zanin M, Sorci G, Franzoso S, Sandona D, Betto R. Sphingosine 1-phosphate signaling is involved in skeletal muscle regeneration. Am J Physiol Cell Physiol 2010; 298:550-58.
9. Kwon YB, Kim CD, Youm JK, et al. Novel synthetic ceramide derivatives increase intracellular calcium levels and promote epidermal keratinocyte differentiation. J Lipid Res 2007; 48:1936-43.
10. Hong JH, Youm JK, Kwon MJ, Park BD, Lee YM, Lee SI, Shin DM, Lee SH. K6PC-5, a direct activator of sphingosine kinase 1, promotes epidermal differentiation through intracellular Ca2+ signaling. J Invest Dermatol 2008; 128:2166-78.
11. Youm JK, Jo H, Hong JH, Shin DM, Kwon MJ, Jeong SK, Park BD, Choi EH, Lee SH. K6PC-5, a sphingosine kinase activator, induces anti-aging effects in intrinsically aged skin through intracellular Ca2+ signaling. J Dermatol Sci 2008; 51:89-102.
12. Bruni P, Donati C. Pleiotropic effects of sphingolipids in skeletal muscle. Cell Mol Life Sci 2008; 65:3725-36.
13. Osada M, Yatomi Y, Ohmori T, Ikeda H, Ozaki Y. Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist. Biochem Biophys Res Commun 2002; 299:483-7. (Pubitemid 35365655)
14. French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN, Eberly JL, Yun JK, Smith CD. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 2003; 63:5962-9. (Pubitemid 37187498)
15. Anastasi S, Giordano S, Sthandier O, Gambarotta G, Maione R, Comoglio P, Amati P. A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation. J Cell Biol 1997; 137:1057-68. (Pubitemid 27251041)
16. Li YP, Schwartz RJ. TNF-alpha regulates early differentiation of C2C12 myoblasts in an autocrine fashion. FASEB J 2001; 15:1413-15.
17. Hait NC, Allegood J, Maceyka M, et al. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 2009; 325:1254-57.
18. Takabe K, Paugh SW, Milstien S, Spiegel S. "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev 2008; 60:181-95. (Pubitemid 351962008)
19. Nincheri P, Bernacchioni C, Cencetti F, Donati C, Bruni P. Sphingosine kinase-1/S1P1 signalling axis negatively regulates mitogenic response elicited by PDGF in mouse myoblasts. Cell Signal 2010; 22:1688-99.
20. Rapizzi E, Donati C, Cencetti F, Nincheri P, Bruni P. Sphingosine 1-phosphate differentially regulates proliferation of C2C12 reserve cells and myoblasts. Mol Cell Biochem 2008; 314:193-99.
21. Taha TA, Argraves KM, Obeid LM. Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy. Biochim Biophys Acta 2004; 1682:48-55.
22. Watterson K, Sankala H, Milstien S, Spiegel S. Pleiotropic actions of sphingosine-1-phosphate. Prog Lipid Res 2003; 42:344-57. (Pubitemid 36411690)